JPS6241210B2 - - Google Patents
Info
- Publication number
- JPS6241210B2 JPS6241210B2 JP52113236A JP11323677A JPS6241210B2 JP S6241210 B2 JPS6241210 B2 JP S6241210B2 JP 52113236 A JP52113236 A JP 52113236A JP 11323677 A JP11323677 A JP 11323677A JP S6241210 B2 JPS6241210 B2 JP S6241210B2
- Authority
- JP
- Japan
- Prior art keywords
- plasma proteins
- solution containing
- buffer
- globulin
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004506 Blood Proteins Human genes 0.000 claims description 27
- 108010017384 Blood Proteins Proteins 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 230000007935 neutral effect Effects 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- 239000003480 eluent Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000012052 hydrophilic carrier Substances 0.000 claims description 11
- 238000004587 chromatography analysis Methods 0.000 claims description 10
- 239000002808 molecular sieve Substances 0.000 claims description 10
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 8
- 239000012266 salt solution Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 229920003169 water-soluble polymer Polymers 0.000 claims description 8
- 239000008351 acetate buffer Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 13
- 108010074605 gamma-Globulins Proteins 0.000 description 12
- 238000000926 separation method Methods 0.000 description 11
- 102000009027 Albumins Human genes 0.000 description 10
- 108010088751 Albumins Proteins 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 108010087504 Beta-Globulins Proteins 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 7
- 102000006734 Beta-Globulins Human genes 0.000 description 6
- 102000008946 Fibrinogen Human genes 0.000 description 6
- 108010049003 Fibrinogen Proteins 0.000 description 6
- 229940012952 fibrinogen Drugs 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000004252 protein component Nutrition 0.000 description 4
- 108010068307 Alpha-Globulins Proteins 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102000002572 Alpha-Globulins Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 238000000760 immunoelectrophoresis Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- DZTHIGRZJZPRDV-UHFFFAOYSA-N N-acetyltryptophan Chemical group C1=CC=C2C(CC(NC(=O)C)C(O)=O)=CNC2=C1 DZTHIGRZJZPRDV-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- -1 cold ethanol Chemical compound 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11323677A JPS5446813A (en) | 1977-09-22 | 1977-09-22 | Separation of plasmaprotein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11323677A JPS5446813A (en) | 1977-09-22 | 1977-09-22 | Separation of plasmaprotein |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5446813A JPS5446813A (en) | 1979-04-13 |
JPS6241210B2 true JPS6241210B2 (sk) | 1987-09-02 |
Family
ID=14607009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11323677A Granted JPS5446813A (en) | 1977-09-22 | 1977-09-22 | Separation of plasmaprotein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5446813A (sk) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105111306A (zh) * | 2015-08-28 | 2015-12-02 | 北京工业大学 | 美洲短吻鳄白蛋白的分离方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686395A (en) * | 1966-04-06 | 1972-08-22 | Biotest Serum Institut Gmbh | Process for preparation of storage stable hepatitis-free serum |
US3998946A (en) * | 1975-04-23 | 1976-12-21 | The Regents Of The University Of Minnesota | Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same |
-
1977
- 1977-09-22 JP JP11323677A patent/JPS5446813A/ja active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686395A (en) * | 1966-04-06 | 1972-08-22 | Biotest Serum Institut Gmbh | Process for preparation of storage stable hepatitis-free serum |
US3998946A (en) * | 1975-04-23 | 1976-12-21 | The Regents Of The University Of Minnesota | Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same |
Also Published As
Publication number | Publication date |
---|---|
JPS5446813A (en) | 1979-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosenberg et al. | Fractionation of the protein components of human erythrocyte membranes | |
EP1729867B1 (en) | A method for chromatographic purification | |
US4743680A (en) | Method for purifying antihemophilic factor | |
US4138287A (en) | Purifying and isolating method for hepatitis virus to use in preparing vaccine | |
JPH0543719B2 (sk) | ||
JPS646201B2 (sk) | ||
SK67895A3 (en) | Displacement chromatography process and purified hemoglobin product | |
JP3438735B2 (ja) | 上清iv、特にiv−4またはコーンフラクションvまたはそれと類似の上清または画分からヒトアルブミンを単離する方法 | |
US4380511A (en) | Purification of bovine thrombin | |
JPH04295432A (ja) | 血液凝固ix因子を含有する複合体 | |
US4675385A (en) | Isolation of human plasma procoagulant protein factor VIII from biological factors | |
US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
JPS6034916A (ja) | 第1x因子および他のビタミンk依存性タンパク質の高純度精製 | |
JPS6241210B2 (sk) | ||
US4603010A (en) | Lipoprotein fractionation | |
JPS59231097A (ja) | 均質ヒト免疫インターフェロンサブタイプ21kおよびその製造法 | |
Hansson et al. | Adsorption and desorption of proteins in metal chelate affinity chromatography: purification of albumin | |
NL7909110A (nl) | Zuivering van gamma-globuline-derivaat. | |
JP4057049B2 (ja) | 置換クロマトグラフィー法および精製ヘモグロビン産物 | |
JPS62191042A (ja) | 血液凝固第8因子吸着体およびそれを用いた血液凝固第8因子の精製法 | |
JPS58159420A (ja) | インタ−ロイキン2の精製法 | |
Pitiot et al. | Protein adsorption on histidyl-aminohexyl-Sepharose 4B: II. Application to the negative one-step affinity purification of human β2-microglobulin and Immunoglobulin G | |
US20020035241A1 (en) | Process for the separation and/or isolation of plasma proteins by means of annular chromatography | |
Mitra et al. | Application of immobilized heparins for isolation of human antithrombin III | |
JPS5810522A (ja) | 不活化トロンビンゲルによるアンチトロンビン3の精製法 |